NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52 | -58.7% | 48,900 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $126 | -77.2% | 48,900 | -63.9% | 0.00% | 0.0% |
| Q1 2023 | $552 | +144.2% | 135,300 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $226 | -100.0% | 45,100 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $589,000 | -2.6% | 45,100 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $605,000 | -11.5% | 47,200 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $684,000 | -14.0% | 44,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $795,000 | +14.4% | 44,900 | +35.6% | 0.00% | 0.0% |
| Q3 2021 | $695,000 | -15.2% | 33,100 | -20.4% | 0.00% | 0.0% |
| Q2 2021 | $820,000 | +24.4% | 41,600 | +83.3% | 0.00% | +50.0% |
| Q1 2021 | $659,000 | +42.3% | 22,700 | +48.4% | 0.00% | 0.0% |
| Q4 2020 | $463,000 | +90.5% | 15,300 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $243,000 | -19.5% | 15,300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $302,000 | +85.3% | 15,300 | +15.0% | 0.00% | 0.0% |
| Q1 2020 | $163,000 | -33.5% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $245,000 | +410.4% | 13,300 | +269.4% | 0.00% | – |
| Q3 2019 | $48,000 | +84.6% | 3,600 | +100.0% | 0.00% | – |
| Q2 2019 | $26,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |